MVA Investors, LLC
Insider CIK 1468223 · EBIO 10% owner · SPHS 10% owner · MRTX 10% owner · PMVP · RAIN Director, 10% owner · PAND 10% owner · ITOS 10% owner · TNGX Director, 10% owner · TYRA 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-07-02 | 2024-07-02 | 95,000 | $8.68 | $824.6K | 108,793 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-07-01 | 2024-07-02 | 110,731 | $8.87 | $982.2K | 203,793 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-06-28 | 2024-07-02 | 29,000 | $8.57 | $248.5K | 314,524 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-06-07 | 2024-06-07 | 77,000 | $6.88 | $529.8K | 343,524 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-06-06 | 2024-06-07 | 63,000 | $7.24 | $456.1K | 420,524 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-05-03 | 2024-05-03 | 60,000 | $7.61 | $456.6K | 483,524 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-05-02 | 2024-05-03 | 75,000 | $7.56 | $567.0K | 543,524 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-05-01 | 2024-05-03 | 75,000 | $7.43 | $557.3K | 618,524 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award deriv | 2024-02-06 | 2024-02-08 | 705,280 | $13.01 | $9.18M | 705,280 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award | 2024-02-06 | 2024-02-08 | 63,412 | $13.01 | $825.0K | 85,939 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-25 | 1,413,475 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-25 | 3,578,036 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-25 | 332,809 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-25 | 287,866 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-25 | 30,518 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-25 | 3,201,440 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-25 | 203,754 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-25 | 3,135,966 | — | $0 | 0 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | P Buy | 2023-10-16 | 2023-10-17 | 500,000 | $6.84 | $3.42M | 8,198,642 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | P Buy | 2023-10-16 | 2023-10-17 | 500,000 | $6.84 | $3.42M | 8,198,642 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | P Buy | 2023-10-13 | 2023-10-17 | 750,000 | $7.07 | $5.30M | 7,698,642 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | P Buy | 2023-10-13 | 2023-10-17 | 750,000 | $7.07 | $5.30M | 7,698,642 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2023-10-09 | 2023-10-11 | 175,000 | $9.97 | $1.74M | 6,948,642 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2023-10-09 | 2023-10-11 | 50,000 | $9.91 | $495.5K | 693,524 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award deriv | 2023-08-11 | 2023-10-11 | 2,340,579 | $5.15 | $12.05M | 2,340,579 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award | 2023-08-11 | 2023-10-11 | 475,000 | $5.15 | $2.45M | 743,542 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | P Buy deriv | 2023-08-11 | 2023-08-15 | 2,340,579 | $5.15 | $12.05M | 2,340,597 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | P Buy | 2023-08-11 | 2023-08-15 | 475,000 | $5.15 | $2.45M | 743,542 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2023-08-11 | 2023-08-15 | 57,533 | $27.80 | $1.60M | 287,866 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2023-08-11 | 2023-08-15 | 1,201,440 | $27.80 | $33.40M | 3,201,440 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2023-08-11 | 2023-08-15 | 1,201,440 | $27.80 | $33.40M | 3,201,440 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2023-08-11 | 2023-08-15 | 57,533 | $27.80 | $1.60M | 287,866 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | S Sale | 2023-02-10 | 2023-02-13 | 65,568 | $13.40 | $878.6K | 22,527 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | S Sale | 2023-02-09 | 2023-02-13 | 200,000 | $13.10 | $2.62M | 88,095 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | P Buy | 2022-10-13 | 2022-10-13 | 70,000 | $4.65 | $325.5K | 7,123,642 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | P Buy | 2022-10-12 | 2022-10-13 | 50,000 | $4.43 | $221.5K | 268,524 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | P Buy | 2022-10-11 | 2022-10-13 | 117,000 | $4.25 | $497.3K | 218,524 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-05 | 88,054 | $41.84 | $3.68M | 3,767,405 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-05 | 11,199 | $44.44 | $497.7K | 2,517 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-05 | 3,138 | $43.36 | $136.1K | 13,716 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-05 | 29,623 | $41.84 | $1.24M | 16,854 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-05 | 7,483 | $45.48 | $340.3K | 3,717,259 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-05 | 33,297 | $44.44 | $1.48M | 3,724,742 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-05 | 9,366 | $43.36 | $406.1K | 3,758,039 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-05 | 2,517 | $45.48 | $114.5K | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-03 | 2022-01-05 | 731 | $50.63 | $37.0K | 46,477 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-03 | 2022-01-05 | 1,682 | $49.37 | $83.0K | 47,208 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-03 | 2022-01-05 | 23,353 | $47.63 | $1.11M | 48,890 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-03 | 2022-01-05 | 17,173 | $50.63 | $869.5K | 3,855,459 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-03 | 2022-01-05 | 39,481 | $49.37 | $1.95M | 3,872,632 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-03 | 2022-01-05 | 432,903 | $47.65 | $20.63M | 3,912,113 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion deriv | 2021-09-17 | 2021-09-17 | 1,480,242 | — | $0 | 0 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion deriv | 2021-09-17 | 2021-09-17 | 15,401 | — | $0 | 0 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion deriv | 2021-09-17 | 2021-09-17 | 713,629 | — | $0 | 0 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion deriv | 2021-09-17 | 2021-09-17 | 95,516 | — | $0 | 0 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion | 2021-09-17 | 2021-09-17 | 288,095 | — | $0 | 288,095 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | P Buy | 2021-09-17 | 2021-09-17 | 625,000 | $16.00 | $10.00M | 6,323,359 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion | 2021-09-17 | 2021-09-17 | 5,698,359 | — | $0 | 5,698,359 | SEC↗ |
| RAIN Rain Therapeutics Inc. | C Conversion deriv | 2021-04-27 | 2021-04-27 | 86,097 | — | $0 | 0 | SEC↗ |
| RAIN Rain Therapeutics Inc. | C Conversion deriv | 2021-04-27 | 2021-04-27 | 3,263,986 | — | $0 | 0 | SEC↗ |
| RAIN Rain Therapeutics Inc. | C Conversion deriv | 2021-04-27 | 2021-04-27 | 79,726 | — | $0 | 79,726 | SEC↗ |
| RAIN Rain Therapeutics Inc. | C Conversion deriv | 2021-04-27 | 2021-04-27 | 3,022,489 | — | $0 | 3,022,489 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2021-04-27 | 2021-04-27 | 1,025,000 | $17.00 | $17.43M | 1,175,000 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2021-04-23 | 2021-04-27 | 125,000 | $16.27 | $2.03M | 150,000 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2021-04-23 | 2021-04-27 | 25,000 | $15.58 | $389.5K | 25,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2021-03-05 | 2021-03-09 | 468,639 | $13.00 | $6.09M | 332,809 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2021-03-05 | 2021-03-09 | 128,805 | $5.60 | $721.3K | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2021-03-05 | 2021-03-09 | 13,996 | $5.60 | $78.4K | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-05 | 2021-03-09 | 4 | $181.00 | $724 | 2,363,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2021-03-05 | 2021-03-09 | 13,996 | — | $0 | 267,334 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-05 | 2021-03-09 | 363,000 | $181.15 | $65.76M | 2,000,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-05 | 2021-03-09 | 1 | $181.00 | $181 | 267,333 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2021-03-05 | 2021-03-09 | 597,444 | — | $0 | 2,363,004 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-05 | 2021-03-09 | 37,000 | $181.15 | $6.70M | 230,333 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2020-10-30 | 2020-10-30 | 37,051 | $5.60 | $207.5K | 13,996 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2020-10-30 | 2020-10-30 | 362,952 | $5.60 | $2.03M | 128,805 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-30 | 2020-10-30 | 37,050 | $202.00 | $7.48M | 216,288 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | F Tax w/h | 2020-10-30 | 2020-10-30 | 2 | $219.97 | $440 | 1,765,560 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2020-10-30 | 2020-10-30 | 362,952 | — | $0 | 1,765,562 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-30 | 2020-10-30 | 362,950 | $202.00 | $73.32M | 1,404,610 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | F Tax w/h | 2020-10-30 | 2020-10-30 | 1 | $219.97 | $220 | 253,338 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2020-10-30 | 2020-10-30 | 37,051 | — | $0 | 253,339 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion deriv | 2020-09-29 | 2020-09-29 | 32,708 | — | $0 | 0 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion deriv | 2020-09-29 | 2020-09-29 | 586,099 | — | $0 | 0 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion deriv | 2020-09-29 | 2020-09-29 | 732,137 | — | $0 | 0 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion deriv | 2020-09-29 | 2020-09-29 | 28,129 | — | $0 | 0 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion | 2020-09-29 | 2020-09-29 | 32,708 | — | $0 | 32,708 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion | 2020-09-29 | 2020-09-29 | 732,137 | — | $0 | 2,268,236 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion | 2020-09-29 | 2020-09-29 | 586,099 | — | $0 | 1,536,099 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion | 2020-09-29 | 2020-09-29 | 28,129 | — | $0 | 60,837 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | P Buy | 2020-09-25 | 2020-09-29 | 950,000 | $18.00 | $17.10M | 950,000 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 9,593,086 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 158,687 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 48,691 | — | $0 | 48,691 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-29 | 1,401,448 | $19.00 | $26.63M | 4,345,016 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-29 | 23,552 | $19.00 | $447.5K | 72,243 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 2,943,568 | — | $0 | 2,943,568 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion deriv | 2020-07-21 | 2020-07-21 | 7,064,136 | — | $0 | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion deriv | 2020-07-21 | 2020-07-21 | 120,460 | — | $0 | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion | 2020-07-21 | 2020-07-21 | 23,622 | — | $0 | 23,622 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion | 2020-07-21 | 2020-07-21 | 1,385,291 | — | $0 | 1,385,291 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | P Buy | 2020-07-21 | 2020-07-21 | 722,222 | $18.00 | $13.00M | 2,107,513 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | J Other | 2019-07-11 | 2019-07-15 | 5,547 | — | $0 | 253,338 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | J Other | 2019-05-23 | 2019-05-23 | 48,169 | — | $0 | 258,885 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | J Other | 2019-04-04 | 2019-04-08 | 180,926 | — | $0 | 307,054 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | J Other | 2019-02-20 | 2019-02-22 | 6,695 | — | $0 | 487,980 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | J Other | 2019-02-11 | 2019-02-13 | 18,955 | — | $0 | 494,675 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | X Exercise deriv | 2017-10-03 | 2017-10-03 | 189,780 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | X Exercise deriv | 2017-10-03 | 2017-10-03 | 78,186 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | X Exercise | 2017-10-03 | 2017-10-03 | 78,186 | $7.86 | $614.5K | 513,630 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | X Exercise | 2017-10-03 | 2017-10-03 | 189,780 | $7.86 | $1.49M | 1,227,774 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy deriv | 2017-01-06 | 2017-01-10 | 51,047 | $5.60 | $285.9K | 51,047 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy deriv | 2017-01-06 | 2017-01-10 | 2,341,786 | $5.60 | $13.11M | 2,341,786 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2017-01-06 | 2017-01-10 | 280,059 | $5.60 | $1.57M | 1,037,994 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2017-01-06 | 2017-01-10 | 6,104 | $5.60 | $34.2K | 435,444 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-06-13 | 2016-06-14 | 177,140 | $2.74 | $485.4K | 297,860 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-06-13 | 2016-06-14 | 864,860 | $2.74 | $2.37M | 1,390,712 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | J Other | 2016-01-04 | 2016-01-05 | 522,500 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale deriv | 2015-09-17 | 2015-09-18 | 1 | $10167583.32 | $10.17M | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale deriv | 2015-09-17 | 2015-09-18 | 1 | $1522965.24 | $1.52M | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2015-09-16 | 2015-09-18 | 22,500 | $45.00 | $1.01M | 522,500 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2015-09-16 | 2015-09-18 | 22,500 | $45.00 | $1.01M | 2,023,232 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2015-01-29 | 2015-02-02 | 50,000 | $20.00 | $1.00M | 2,000,732 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2015-01-29 | 2015-02-02 | 500,000 | $20.00 | $10.00M | 500,000 | SEC↗ |
| SPHS SOPHIRIS BIO INC. | S Sale | 2014-12-15 | 2014-12-17 | 796,772 | $0.61 | $486.0K | 1,518,613 | SEC↗ |
| SPHS SOPHIRIS BIO INC. | S Sale | 2014-12-15 | 2014-12-17 | 84,707 | $0.61 | $51.7K | 161,447 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2013-10-24 | 2013-10-28 | 40,000 | $17.50 | $700.0K | 429,341 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2013-10-24 | 2013-10-28 | 360,000 | $17.50 | $6.30M | 1,950,733 | SEC↗ |
| SPHS SOPHIRIS BIO INC. | P Buy | 2013-08-16 | 2013-08-20 | 1,450,000 | $5.00 | $7.25M | 2,315,385 | SEC↗ |
| SPHS SOPHIRIS BIO INC. | P Buy | 2013-08-16 | 2013-08-20 | 150,000 | $5.00 | $750.0K | 246,153 | SEC↗ |